Free Trial
→ Buffett’s favorite chart just hit 209% – here’s what that means for gold (From Golden Portfolio) (Ad) Buy QGEN Stock  Free QGEN Stock Alerts

Qiagen (QGEN) Financials

Qiagen logo
$42.19 -0.62 (-1.46%)
Closing price 05/6/2025 03:59 PM Eastern
Extended Trading
$42.47 +0.28 (+0.67%)
As of 08:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Qiagen

Annual Income Statements for Qiagen

This table shows Qiagen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 116 130 80 40 190 -41 359 513 423 341 84
Consolidated Net Income / (Loss)		 117 130 80 40 190 -41 359 513 423 341 84
Net Income / (Loss) Continuing Operations		 117 130 80 40 190 -41 359 513 423 341 84
Total Pre-Tax Income 		119 136 57 114 226 -78 439 626 513 430 121
Total Operating Income		 162 179 99 153 267 -26 386 630 531 410 98
Total Gross Profit		 865 827 845 923 1,001 1,005 1,233 1,451 1,385 1,234 967
Total Revenue		 1,345 1,281 1,338 1,418 1,502 1,526 1,870 2,252 2,142 1,965 1,978
Operating Revenue		 1,345 1,281 1,338 1,418 1,502 1,526 1,870 2,252 2,142 1,965 1,978
Total Cost of Revenue		 480 454 493 495 501 521 638 801 757 732 1,011
Operating Cost of Revenue		 480 454 493 495 501 521 638 801 757 732 1,011
Total Operating Expenses		 704 647 746 769 734 1,031 846 821 853 824 870
Selling, General & Admin Expense		 127 - - 102 105 112 112 128 130 119 113
Marketing Expense		 376 360 376 376 392 392 414 456 474 460 451
Research & Development Expense		 164 147 150 154 162 157 149 190 190 199 193
Amortization Expense		 37 39 39 39 39 30 21 19 15 11 9.60
Restructuring Charge		 - 102 181 98 29 200 151 28 45 35 102
Total Other Income / (Expense), net		 -42 -43 -42 -39 -41 -52 53 -4.25 -19 20 23
Interest Expense		 39 37 39 50 67 74 71 54 58 53 44
Interest & Investment Income		 3.96 4.75 6.78 11 21 22 10 9.56 33 79 68
Other Income / (Expense), net		 -6.94 -11 -9.67 -0.00 5.60 0.43 114 41 6.74 -5.71 -0.74
Income Tax Expense		 2.46 6.40 -23 74 35 -36 80 113 89 89 38
Basic Earnings per Share		 $0.50 $0.56 $0.34 $0.18 $0.84 ($0.18) $1.57 $2.25 $1.86 $1.50 $0.38
Weighted Average Basic Shares Outstanding		 232.64M 233.48M 234.80M 228.07M 226.64M 226.78M 228.43M 227.98M 227.58M 228.15M 222.62M
Diluted Earnings per Share		 $0.48 $0.55 $0.34 $0.17 $0.82 ($0.18) $1.53 $2.21 $1.84 $1.48 $0.37
Weighted Average Diluted Shares Outstanding		 242.81M 238.65M 238.99M 233.01M 233.46M 226.78M 234.21M 232.03M 230.14M 230.62M 224.72M
Weighted Average Basic & Diluted Shares Outstanding		 232.02M 233.01M 234.56M 226.56M 225.51M 227.75M 227.99M 227.07M 227.72M 228.20M 222.29M

Quarterly Income Statements for Qiagen

No quarterly income statements for Qiagen are available.

Annual Cash Flow Statements for Qiagen

This table details how cash moves in and out of Qiagen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 62 -103 149 219 501 -530 -31 283 -150 -63 -4.53
Net Cash From Operating Activities		 288 317 342 287 359 331 458 639 715 459 674
Net Cash From Continuing Operating Activities		 288 317 342 287 359 331 458 639 715 459 674
Net Income / (Loss) Continuing Operations		 117 130 80 40 190 -41 359 513 423 341 84
Consolidated Net Income / (Loss)		 117 130 80 40 190 -41 359 513 423 341 84
Depreciation Expense		 201 191 213 216 206 231 205 215 208 205 203
Amortization Expense		 15 20 20 25 36 41 42 32 34 30 18
Non-Cash Adjustments To Reconcile Net Income		 75 42 90 36 46 210 -70 14 91 59 256
Changes in Operating Assets and Liabilities, net		 -120 -66 -62 -31 -118 -110 -79 -135 -41 -176 112
Net Cash From Investing Activities		 -408 -146 -179 -464 -211 -222 -443 -202 -727 -88 -249
Net Cash From Continuing Investing Activities		 -408 -146 -179 -464 -211 -222 -443 -202 -727 -88 -249
Purchase of Property, Plant & Equipment		 -87 -98 -75 -90 -110 -118 -133 -190 -129 -150 -167
Acquisitions		 -171 -87 -110 -85 -214 -225 -411 -17 -84 -163 -4.07
Purchase of Investments		 -430 -324 -520 -455 -577 -294 -50 -400 -1,387 -979 -688
Sale and/or Maturity of Investments		 276 368 534 189 692 391 207 360 883 1,271 585
Other Investing Activities, net		 3.61 -5.98 -8.80 -23 -19 23 -58 45 -9.77 -67 25
Net Cash From Financing Activities		 193 -259 -11 387 360 -639 -50 -150 -126 -434 -423
Net Cash From Continuing Financing Activities		 193 -259 -11 387 360 -639 -50 -150 -126 -434 -423
Repayment of Debt		 -392 -253 -18 140 486 -518 -365 -43 -480 -400 -602
Repurchase of Common Equity		 -127 -21 0.00 -61 -105 -74 -239 -100 0.00 0.00 -292
Issuance of Debt		 733 1.59 0.00 330 0.00 0.00 557 0.00 371 0.00 494
Other Financing Activities, net		 -103 3.33 0.78 -74 -97 -49 -11 -15 -17 -34 -23
Effect of Exchange Rate Changes		 -11 -15 -2.77 8.83 -7.18 0.83 4.20 -3.68 -13 -0.56 -5.96
Cash Interest Paid		 24 21 18 20 26 30 25 22 23 20 24
Cash Income Taxes Paid		 13 34 23 40 29 41 43 102 120 82 16

Quarterly Cash Flow Statements for Qiagen

No quarterly cash flow statements for Qiagen are available.

Annual Balance Sheets for Qiagen

This table presents Qiagen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 4,454 4,179 4,308 5,039 5,748 5,264 5,928 6,147 6,288 6,115 5,690
Total Current Assets		 1,149 961 1,038 1,648 2,155 1,512 1,599 2,110 2,394 2,148 1,960
Cash & Equivalents		 393 290 439 658 1,159 622 597 881 731 668 664
Short-Term Investments		 184 131 93 359 235 108 14 185 688 390 489
Accounts Receivable		 265 274 278 329 352 376 381 362 324 382 349
Inventories, net		 132 137 137 156 163 171 291 328 358 398 279
Prepaid Expenses		 114 70 67 99 109 - - 355 294 310 178
Plant, Property, & Equipment, net		 428 443 437 494 512 356 427 638 662 765 754
Total Noncurrent Assets		 2,878 2,775 2,834 2,896 3,082 3,396 3,902 3,399 3,232 3,203 2,976
Goodwill		 1,888 1,876 1,926 2,013 2,109 2,166 2,389 2,351 2,353 2,476 2,425
Intangible Assets		 727 636 557 499 475 751 884 627 545 527 304
Other Noncurrent Operating Assets		 258 261 283 345 455 392 529 421 334 200 247
Total Liabilities & Shareholders' Equity		 4,454 4,179 4,308 5,039 5,748 5,264 5,928 6,147 6,288 6,115 5,690
Total Liabilities		 1,796 1,611 1,701 2,498 3,113 2,940 3,445 3,050 2,821 2,307 2,122
Total Current Liabilities		 432 268 308 325 972 951 571 1,517 975 1,079 544
Short-Term Debt		 131 - - 0.00 503 285 43 848 390 588 53
Accounts Payable		 46 52 51 59 69 85 118 101 99 84 83
Accrued Expenses		 224 192 230 242 263 - - 569 486 407 407
Total Noncurrent Liabilities		 1,365 1,343 1,393 2,173 2,141 1,989 2,874 1,533 1,847 1,228 1,579
Long-Term Debt		 1,041 1,049 1,067 1,758 1,671 1,419 1,875 1,094 1,472 922 1,338
Other Noncurrent Operating Liabilities		 207 224 285 338 407 542 953 439 375 306 241
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 - - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,658 2,568 2,607 2,541 2,635 3,159 3,199 3,097 3,467 3,808 3,567
Total Preferred & Common Equity		 2,650 2,566 2,607 2,541 2,635 2.70 2.70 3,097 3,467 3,808 3,567
Total Common Equity		 2,650 2,566 2,607 2,541 2,635 1,368 1,359 3,097 3,467 3,808 3,567
Common Stock		 1,826 1,768 1,797 1,633 1,745 2.70 2.70 1,821 1,871 1,918 1,669
Retained Earnings		 1,126 1,209 1,263 1,248 1,380 948 998 1,792 2,160 2,457 2,448
Treasury Stock		 -167 -152 -120 -119 -179 112 118 -190 -160 -133 -75
Accumulated Other Comprehensive Income / (Loss)		 -135 -259 -334 -221 -311 - - -327 -404 -434 -475

Quarterly Balance Sheets for Qiagen

No quarterly balance sheets for Qiagen are available.

Annual Metrics and Ratios for Qiagen

This table displays calculated financial ratios and metrics derived from Qiagen's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 3.29% -4.74% 4.45% 5.95% 5.95% 1.64% 22.53% 20.39% -4.89% -8.23% 0.66%
EBITDA Growth		 39.83% 2.55% -15.17% 22.31% 30.29% -52.05% 203.46% 22.71% -15.00% -18.02% -50.19%
EBIT Growth		 134.76% 9.17% -47.23% 72.08% 77.41% -109.44% 2,048.17% 33.95% -19.76% -24.89% -76.01%
NOPAT Growth		 35.13% 8.02% -18.48% -61.15% 314.94% -108.14% 1,826.34% 63.40% -14.98% -25.81% -79.29%
Net Income Growth		 69.23% 11.09% -38.18% -49.70% 371.31% -121.77% 966.45% 42.71% -17.44% -19.35% -75.51%
EPS Growth		 69.23% 11.09% -38.18% -50.00% 382.35% -121.95% 950.00% 42.71% -17.44% -19.35% -75.51%
Operating Cash Flow Growth		 11.20% 10.26% 7.59% -16.05% 25.36% -7.97% 38.38% 39.58% 11.93% -35.76% 46.60%
Free Cash Flow Firm Growth		 530.07% 142.43% -15.10% -144.47% 206.42% 142.61% -176.77% 219.73% 145.57% -104.87% 2,231.49%
Invested Capital Growth		 2.01% -1.76% -1.70% 4.47% 4.06% -7.05% 15.33% 8.51% -1.59% 8.95% -10.66%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 64.34% 64.53% 63.13% 65.08% 66.65% 65.86% 65.91% 64.43% 64.65% 62.77% 48.90%
EBITDA Margin		 27.58% 29.69% 24.12% 27.84% 34.23% 16.15% 40.00% 40.77% 36.44% 32.55% 16.11%
Operating Margin		 12.02% 14.01% 7.39% 10.82% 17.75% -1.71% 20.66% 27.98% 24.82% 20.86% 4.94%
EBIT Margin		 11.51% 13.19% 6.66% 10.82% 18.12% -1.68% 26.77% 29.79% 25.13% 20.57% 4.90%
Profit (Net Income) Margin		 8.70% 10.14% 6.00% 2.85% 12.68% -2.72% 19.20% 22.77% 19.76% 17.37% 4.23%
Tax Burden Percent		 97.94% 95.30% 141.11% 35.32% 84.34% 53.30% 81.73% 81.91% 82.56% 79.41% 69.00%
Interest Burden Percent		 77.15% 80.68% 63.83% 74.55% 82.94% 302.58% 87.76% 93.30% 95.24% 106.33% 124.93%
Effective Tax Rate		 2.06% 4.70% -41.11% 64.68% 15.66% 0.00% 18.27% 18.09% 17.44% 20.59% 31.00%
Return on Invested Capital (ROIC)		 4.92% 5.30% 4.40% 1.69% 6.71% -0.56% 9.24% 13.52% 11.13% 7.97% 1.67%
ROIC Less NNEP Spread (ROIC-NNEP)		 -2.90% -1.42% -5.77% -0.47% 2.19% -6.37% 27.37% 13.00% 8.77% 11.49% 6.36%
Return on Net Nonoperating Assets (RNNOA)		 -0.57% -0.33% -1.30% -0.12% 0.64% -0.88% 2.06% 2.77% 1.76% 1.41% 0.60%
Return on Equity (ROE)		 4.35% 4.97% 3.10% 1.57% 7.36% -1.43% 11.30% 16.28% 12.90% 9.38% 2.27%
Cash Return on Invested Capital (CROIC)		 2.92% 7.08% 6.11% -2.68% 2.74% 6.75% -5.00% 5.36% 12.74% -0.60% 12.93%
Operating Return on Assets (OROA)		 3.62% 3.91% 2.10% 3.28% 5.05% -0.47% 8.95% 11.11% 8.66% 6.52% 1.64%
Return on Assets (ROA)		 2.74% 3.01% 1.89% 0.86% 3.53% -0.75% 6.42% 8.49% 6.81% 5.50% 1.42%
Return on Common Equity (ROCE)		 4.33% 4.96% 3.10% 1.57% 7.36% -0.99% 4.85% 11.52% 12.90% 9.38% 2.27%
Return on Equity Simple (ROE_SIMPLE)		 4.41% 5.06% 3.08% 1.59% 7.23% -1,534.23% 0.00% 16.55% 12.21% 8.96% 2.34%
Net Operating Profit after Tax (NOPAT)		 158 171 139 54 225 -18 316 516 439 326 67
NOPAT Margin		 11.78% 13.35% 10.42% 3.82% 14.97% -1.20% 16.89% 22.92% 20.49% 16.56% 3.41%
Net Nonoperating Expense Percent (NNEP)		 7.81% 6.73% 10.17% 2.16% 4.53% 5.82% -18.13% 0.52% 2.36% -3.53% -4.68%
Return On Investment Capital (ROIC_SIMPLE)		 4.13% 4.73% 3.80% 1.26% 4.68% -0.38% 6.17% 10.24% 8.24% 6.12% 1.36%
Cost of Revenue to Revenue		 35.66% 35.47% 36.87% 34.92% 33.35% 34.14% 34.09% 35.57% 35.35% 37.23% 51.10%
SG&A Expenses to Revenue		 9.42% 0.00% 0.00% 7.20% 6.96% 7.35% 5.97% 5.69% 6.06% 6.07% 5.73%
R&D to Revenue		 12.17% 11.46% 11.20% 10.87% 10.78% 10.31% 7.97% 8.44% 8.87% 10.10% 9.78%
Operating Expenses to Revenue		 52.31% 50.52% 55.74% 54.26% 48.90% 67.57% 45.25% 36.45% 39.84% 41.91% 43.96%
Earnings before Interest and Taxes (EBIT)		 155 169 89 153 272 -26 501 671 538 404 97
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 371 380 323 395 514 247 748 918 780 640 319
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.90 2.29 2.29 2.62 2.71 5.10 8.12 3.75 2.99 2.38 2.77
Price to Tangible Book Value (P/TBV)		 144.20 109.03 48.08 231.03 139.16 0.00 0.00 98.10 18.23 11.25 11.79
Price to Revenue (P/Rev)		 3.74 4.59 4.47 4.69 4.76 4.58 5.90 5.16 4.85 4.61 4.99
Price to Earnings (P/E)		 43.21 45.17 74.40 164.57 37.56 0.00 30.71 22.65 24.52 26.55 118.17
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 2.31% 2.21% 1.34% 0.61% 2.66% 0.00% 3.26% 4.41% 4.08% 3.77% 0.85%
Enterprise Value to Invested Capital (EV/IC)		 1.73 2.04 2.07 2.25 2.32 3.07 3.87 3.14 2.77 2.23 2.66
Enterprise Value to Revenue (EV/Rev)		 4.19 5.08 4.87 5.21 5.28 6.38 7.57 5.55 5.05 4.84 5.11
Enterprise Value to EBITDA (EV/EBITDA)		 15.18 17.11 20.20 18.72 15.43 39.48 18.93 13.60 13.87 14.87 31.75
Enterprise Value to EBIT (EV/EBIT)		 36.39 38.52 73.10 48.16 29.14 0.00 28.29 18.62 20.10 23.54 104.33
Enterprise Value to NOPAT (EV/NOPAT)		 35.56 38.05 46.73 136.37 35.28 0.00 44.85 24.20 24.66 29.23 150.06
Enterprise Value to Operating Cash Flow (EV/OCF)		 19.56 20.50 19.08 25.77 22.06 29.42 30.94 19.54 15.13 20.71 15.02
Enterprise Value to Free Cash Flow (EV/FCFF)		 59.83 28.52 33.64 0.00 86.52 43.76 0.00 61.08 21.55 0.00 19.41
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.44 0.41 0.41 0.69 0.83 0.54 0.60 0.63 0.54 0.40 0.39
Long-Term Debt to Equity		 0.39 0.41 0.41 0.69 0.63 0.45 0.59 0.35 0.42 0.24 0.38
Financial Leverage		 0.20 0.23 0.22 0.25 0.29 0.14 0.08 0.21 0.20 0.12 0.09
Leverage Ratio		 1.59 1.65 1.64 1.82 2.08 1.90 1.76 1.92 1.89 1.71 1.60
Compound Leverage Factor		 1.22 1.33 1.05 1.35 1.73 5.75 1.55 1.79 1.80 1.81 2.00
Debt to Total Capital		 30.60% 29.00% 29.04% 40.90% 45.21% 35.04% 37.48% 38.54% 34.94% 28.39% 28.06%
Short-Term Debt to Total Capital		 3.42% 0.00% 0.00% 0.00% 10.46% 5.87% 0.83% 16.82% 7.31% 11.06% 1.08%
Long-Term Debt to Total Capital		 27.18% 29.00% 29.04% 40.90% 34.75% 29.17% 36.65% 21.72% 27.63% 17.34% 26.98%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 36.82% 35.96% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.22% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 69.18% 70.94% 70.96% 59.10% 54.79% 28.14% 26.56% 61.46% 65.06% 71.61% 71.94%
Debt to EBITDA		 3.16 2.76 3.31 4.46 4.23 6.91 2.56 2.12 2.39 2.36 4.37
Net Debt to EBITDA		 1.61 1.65 1.66 1.88 1.52 3.89 1.73 0.95 0.57 0.71 0.75
Long-Term Debt to EBITDA		 2.81 2.76 3.31 4.46 3.25 5.75 2.51 1.19 1.89 1.44 4.20
Debt to NOPAT		 7.40 6.13 7.65 32.45 9.67 -93.13 6.07 3.76 4.24 4.64 20.64
Net Debt to NOPAT		 3.76 3.67 3.84 13.68 3.47 -52.37 4.10 1.70 1.01 1.39 3.54
Long-Term Debt to NOPAT		 6.57 6.13 7.65 32.45 7.43 -77.54 5.94 2.12 3.35 2.83 19.85
Altman Z-Score		 2.64 3.23 3.10 2.64 2.38 2.08 2.96 3.53 3.58 3.67 4.10
Noncontrolling Interest Sharing Ratio		 0.33% 0.20% 0.04% 0.00% 0.00% 30.90% 57.11% 29.23% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.66 3.58 3.36 5.07 2.22 1.59 2.80 1.39 2.46 1.99 3.61
Quick Ratio		 1.95 2.59 2.63 4.14 1.80 1.16 1.74 0.94 1.79 1.33 2.76
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 94 228 194 -86 92 222 -171 204 502 -24 521
Operating Cash Flow to CapEx		 332.69% 325.05% 458.69% 318.51% 327.49% 280.49% 344.77% 336.49% 553.51% 306.90% 402.90%
Free Cash Flow to Firm to Interest Expense		 2.39 6.10 4.96 -1.73 1.36 3.00 -2.39 3.75 8.60 -0.46 11.89
Operating Cash Flow to Interest Expense		 7.32 8.49 8.75 5.77 5.34 4.46 6.42 11.73 12.26 8.60 15.36
Operating Cash Flow Less CapEx to Interest Expense		 5.12 5.88 6.85 3.96 3.71 2.87 4.56 8.24 10.04 5.80 11.55
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.31 0.30 0.32 0.30 0.28 0.28 0.33 0.37 0.34 0.32 0.34
Accounts Receivable Turnover		 5.12 4.75 4.85 4.67 4.41 4.19 4.94 6.06 6.24 5.57 5.41
Inventory Turnover		 3.68 3.38 3.61 3.38 3.14 3.12 2.76 2.59 2.21 1.93 2.98
Fixed Asset Turnover		 3.08 2.94 3.04 3.05 2.99 3.52 4.77 4.23 3.29 2.75 2.61
Accounts Payable Turnover		 9.89 9.23 9.53 8.97 7.79 6.76 6.28 7.30 7.57 8.00 12.08
Days Sales Outstanding (DSO)		 71.24 76.80 75.31 78.20 82.72 87.03 73.85 60.19 58.45 65.53 67.45
Days Inventory Outstanding (DIO)		 99.08 108.00 101.04 107.84 116.17 116.83 132.20 140.99 165.27 188.67 122.34
Days Payable Outstanding (DPO)		 36.91 39.54 38.30 40.71 46.86 53.99 58.08 49.99 48.21 45.62 30.23
Cash Conversion Cycle (CCC)		 133.41 145.26 138.05 145.32 152.03 149.86 147.97 151.19 175.51 208.57 159.57
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 3,253 3,196 3,142 3,282 3,415 3,175 3,661 3,973 3,910 4,260 3,806
Invested Capital Turnover		 0.42 0.40 0.42 0.44 0.45 0.46 0.55 0.59 0.54 0.48 0.49
Increase / (Decrease) in Invested Capital		 64 -57 -54 140 133 -241 487 312 -63 350 -454
Enterprise Value (EV)		 5,631 6,509 6,517 7,389 7,932 9,733 14,165 12,487 10,819 9,514 10,117
Market Capitalization		 5,028 5,878 5,982 6,648 7,151 6,984 11,029 11,611 10,376 9,062 9,878
Book Value per Share		 $11.33 $11.06 $11.19 $10.83 $11.63 $6.07 $5.97 $13.58 $15.23 $16.72 $15.63
Tangible Book Value per Share		 $0.15 $0.23 $0.53 $0.12 $0.23 ($6.87) ($8.40) $0.52 $2.50 $3.54 $3.67
Total Capital		 3,830 3,617 3,674 4,299 4,809 4,863 5,117 5,038 5,328 5,318 4,959
Total Debt		 1,172 1,049 1,067 1,758 2,174 1,704 1,918 1,942 1,861 1,510 1,392
Total Long-Term Debt		 1,041 1,049 1,067 1,758 1,671 1,419 1,875 1,094 1,472 922 1,338
Net Debt		 595 628 535 741 781 958 1,296 876 443 452 239
Capital Expenditures (CapEx)		 87 98 74 90 110 118 133 190 129 150 167
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 272 272 197 306 292 109 459 374 391 598 317
Debt-free Net Working Capital (DFNWC)		 848 693 729 1,323 1,686 846 1,070 1,440 1,809 1,656 1,470
Net Working Capital (NWC)		 717 693 729 1,323 1,183 560 1,028 592 1,419 1,068 1,416
Net Nonoperating Expense (NNE)		 41 41 59 14 34 23 -43 3.48 16 -16 -16
Net Nonoperating Obligations (NNO)		 595 628 535 741 781 16 463 876 443 452 239
Total Depreciation and Amortization (D&A)		 216 211 234 241 242 272 247 247 242 235 222
Debt-free, Cash-free Net Working Capital to Revenue		 20.19% 21.25% 14.72% 21.61% 19.46% 7.17% 24.56% 16.63% 18.24% 30.45% 16.01%
Debt-free Net Working Capital to Revenue		 63.08% 54.10% 54.50% 93.34% 112.26% 55.39% 57.23% 63.94% 84.47% 84.27% 74.29%
Net Working Capital to Revenue		 53.33% 54.10% 54.50% 93.34% 78.76% 36.71% 54.96% 26.30% 66.28% 54.36% 71.59%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.53 $0.57 $0.36 $0.19 $0.89 ($0.19) $0.00 $0.00 $1.97 $1.54 $0.38
Adjusted Weighted Average Basic Shares Outstanding		 219.16M 219.95M 221.43M 215.09M 213.73M 213.86M 0.00 0.00 214.62M 221.81M 222.62M
Adjusted Diluted Earnings per Share		 $0.51 $0.57 $0.36 $0.18 $0.87 ($0.19) $0.00 $0.00 $1.95 $1.52 $0.37
Adjusted Weighted Average Diluted Shares Outstanding		 227.54M 223.42M 225.38M 219.74M 220.16M 213.86M 0.00 0.00 217.03M 224.21M 224.72M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 218.58M 219.50M 221.20M 213.66M 212.67M 214.78M 0.00 0.00 214.75M 221.86M 222.29M
Normalized Net Operating Profit after Tax (NOPAT)		 158 268 196 176 256 220 439 539 476 354 138
Normalized NOPAT Margin		 11.78% 20.95% 14.62% 12.42% 17.03% 14.38% 23.49% 23.93% 22.22% 17.99% 6.97%
Pre Tax Income Margin		 8.88% 10.64% 4.25% 8.07% 15.03% -5.10% 23.50% 27.79% 23.94% 21.87% 6.12%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 3.93 4.52 2.28 3.09 4.04 -0.35 7.02 12.31 9.22 7.57 2.21
NOPAT to Interest Expense		 4.03 4.57 3.57 1.09 3.34 -0.25 4.43 9.47 7.52 6.09 1.54
EBIT Less CapEx to Interest Expense		 1.73 1.91 0.38 1.28 2.41 -1.94 5.16 8.83 7.01 4.77 -1.60
NOPAT Less CapEx to Interest Expense		 1.83 1.96 1.67 -0.72 1.71 -1.84 2.57 5.99 5.30 3.29 -2.28
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 108.51% 16.03% 0.00% 150.94% 54.99% -179.59% 66.43% 19.51% 0.00% 0.00% 349.44%

Quarterly Metrics and Ratios for Qiagen

No quarterly metrics and ratios for Qiagen are available.

Frequently Asked Questions About Qiagen's Financials

When does Qiagen's fiscal year end?

According to the most recent income statement we have on file, Qiagen's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Qiagen's net income changed over the last 10 years?

Qiagen's net income appears to be on an upward trend, with a most recent value of $83.59 million in 2024, falling from $116.93 million in 2014. The previous period was $341.30 million in 2023. View Qiagen's forecast to see where analysts expect Qiagen to go next.

What is Qiagen's operating income?
Qiagen's total operating income in 2024 was $97.71 million, based on the following breakdown:
  • Total Gross Profit: $967.35 million
  • Total Operating Expenses: $869.64 million
How has Qiagen revenue changed over the last 10 years?

Over the last 10 years, Qiagen's total revenue changed from $1.34 billion in 2014 to $1.98 billion in 2024, a change of 47.1%.

How much debt does Qiagen have?

Qiagen's total liabilities were at $2.12 billion at the end of 2024, a 8.0% decrease from 2023, and a 18.1% increase since 2014.

How much cash does Qiagen have?

In the past 10 years, Qiagen's cash and equivalents has ranged from $290.01 million in 2015 to $1.16 billion in 2018, and is currently $663.56 million as of their latest financial filing in 2024.

How has Qiagen's book value per share changed over the last 10 years?

Over the last 10 years, Qiagen's book value per share changed from 11.33 in 2014 to 15.63 in 2024, a change of 38.0%.


Related Companies

This page (NYSE:QGEN) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...
Crypto 101 Media | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Virtually Limitless Energy?
A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...
Stansberry Research | Sponsored
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...
Brownstone Research | Sponsored